In vitro diagnostics (IVDs) test a sample of tissue or bodily fluid in an effort to diagnose a disease or condition. Effectively used, IVDs help to reduce hospital stays, support patients to look after their own health and release resources for use elsewhere in the NHS, resulting in a healthier population and stronger economic growth.


IMPORTANT UPDATE:

As of 1st October, BIVDA has a new email domain.
The convention for our new email addresses is [first name]@bivda.org.uk. This also applies to our enquiries@bivda.org.uk address.

All other contact information for us remains the same:

Website: www.bivda.org.uk

LinkedIn: British In Vitro Diagnostics Association

Twitter: @BIVDA

Tel.: 0845 6188 224

 

Please update your records with our new contact information. If you have any questions, please contact the BIVDA team at any time.


Industry

Find out more about how BIVDA represents the IVD industry on behalf of its members. You can also access our Events Diary and Members’ Area. If you are not already a member, discover how you can ‘join us’!

Read More

Healthcare Professionals

If you are a healthcare professional, please click here to find out more about the value of IVDs and how they can deliver improved outcomes for patients and the NHS.

Read More

The Value of IVDs

Ever wondered what an IVD is? Want to know more about how diagnostics are helping patients? Keen to discover more about the role of the industry? You can find out the answer to all of these questions and more, here.

Read More

Latest Blog

Increased funding is not enough to sustain the NHS. We need to make better use of in vitro diagnostics to ensure a successful future - After months of speculation, the Prime Minister finally unveiled her long-awaited birthday present for the NHS yesterday. While the promise of additional funding is always welcome, many questions remain unanswered, including: how will the increase be funded? How will the money be spent? Will the money be enough?

Read More

Latest Report

Three simple tests could save the NHS at least £6.9 billion - Research commissioned by Innovate UK and the British In Vitro Diagnostics Association (BIVDA) reveals that the NHS could save over £6.9 billion in five years through quick adoption of new diagnostic tests as they come onto the market. In turn, these savings could help tackle the annual NHS shortfall, widely expected to reach £20 billion by 2022

Download Here

Members

Here you can access a wide range of information on events, briefings and resources for members of BIVDA.

Enter Now

Find A Member

Here you can access a wide range of information on the Members of BIVDA.

Search Now